Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127295531 | 12729553 | 1 | I | 20160902 | 20160909 | 20160909 | EXP | IL-JNJFOC-20160905610 | JANSSEN | BAZ RC, SHAIN KH, ALSINA M, BRAYER J, RASHAL T, COOKSEY J, ET AL. PHASE I TRIAL OF THE COMBINATION OF SELINEXOR (SEL), LIPOSOMAL DOXORUBICIN (DOX) AND DEXAMETHASONE (DEX) FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM). JOURNAL OF CLINICAL ONCOLOGY 2016;34 (SUPPL 15):8013. | 0.00 | Y | 0.00000 | 20160909 | OT | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127295531 | 12729553 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | U | U | 50718 | 20 | MG/M**2 | LIPOSOME INJECTION | ||||||
| 127295531 | 12729553 | 2 | SS | SELINEXOR | SELINEXOR | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127295531 | 12729553 | 3 | SS | SELINEXOR | SELINEXOR | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127295531 | 12729553 | 4 | SS | SELINEXOR | SELINEXOR | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127295531 | 12729553 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127295531 | 12729553 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127295531 | 12729553 | 7 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127295531 | 12729553 | 1 | Plasma cell myeloma |
| 127295531 | 12729553 | 2 | Plasma cell myeloma |
| 127295531 | 12729553 | 3 | Plasma cell myeloma |
| 127295531 | 12729553 | 4 | Plasma cell myeloma |
| 127295531 | 12729553 | 5 | Plasma cell myeloma |
| 127295531 | 12729553 | 6 | Plasma cell myeloma |
| 127295531 | 12729553 | 7 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127295531 | 12729553 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127295531 | 12729553 | Anaemia | |
| 127295531 | 12729553 | Diarrhoea | |
| 127295531 | 12729553 | Fatigue | |
| 127295531 | 12729553 | Hyperglycaemia | |
| 127295531 | 12729553 | Hyponatraemia | |
| 127295531 | 12729553 | Nausea | |
| 127295531 | 12729553 | Neutropenia | |
| 127295531 | 12729553 | Thrombocytopenia | |
| 127295531 | 12729553 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |